France - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)

Since 2014, France Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) increased 1.9% year on year. In 2019, the country was ranked number 5 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) with €412.39 Per Capita. France is overtaken by Belgium, which was number 4 with €420.62 Per Capita and is followed by Luxembourg with €398.82 Per Capita. Switzerland topped the ranking with €665.57 Per Capita in 2019, that is a growth of 3.2% versus 2018. Switzerland recorded the best 5 years average growth at +5.4% per year, while Portugal was the worst growing country at -12.9% per year.

Loading...

Date Euros Per Capita
2019 412.39
2018 409.89
2017 404.65
2016 398.59
2015 371.03
Download all data from 2006 to 2019

How does France rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?

# 23 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
665.57 2019 +3.1 % +5.3 % View data
2 #2
Germany
524.79 2019 +2.3 % +3.0 % View data
4 #4
Belgium
420.62 2019 +0.4 % +3.9 % View data
5 #5
France
412.39 2019 +0.6 % +1.9 % View data
6 #6
Luxembourg
398.82 2019 -0.2 % +1.2 % View data
Compare all 23 countries

Go Top